21 April 2025 in Ear, Nose & Throat Journal
The primary goal of sinonasal surgery is to improve a patient’s quality of life, which is generally achieved by enhancing drug delivery (eg, saline rinses, nasal steroids) and nasal airflow. Both drug delivery and nasal airflow are dependent on the anatomic structure of the sinonasal cavity and the relationship between this anatomy and airflow and drug delivery can be studied using computational fluid dynamics (CFD). CFD generally uses computed tomography scans and computational algorithms to predict airflow or drug delivery and can help us understand surgical outcomes and optimize drug delivery for patients. This study employs CFD to simulate nasal airflow dynamics and optimize drug delivery in the nasal cavity to highlight the utility of CFD for studying sinonasal disease. Utilizing COMSOL Multiphysics software, we developed detailed models to analyze changes in airflow characteristics before and after functional endoscopic sinus surgery, focusing on pressure distribution, velocity profiles, streamline patterns, and heat transfer. This research examines the impact of varying levels of nasal airway obstruction on airflow and heat transfer. In addition, we explore the characteristics of nasal drug delivery by simulating diverse spray parameters, including particle size, spray angle, and velocity. Our comprehensive approach allows for the visualization of drug particle trajectories and deposition patterns, providing crucial insights for enhancing surgical outcomes and improving targeted drug administration. By integrating patient-specific nasal cavity models and considering factors such as airway outlet pressure, this study offers valuable data on pressure cross-sections, flow rate variations, and particle behavior within the nasal passages. The findings of this research can be useful for both surgical planning and the development of more effective nasal drug delivery methods, potentially leading to enhanced clinical outcomes in respiratory treatment.
11 March 2025 in Current Allergy and Asthma Reports
24 May 2025 in Ear, Nose & Throat Journal
Objectives: This study reviews current postoperative care recommendations following endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS), with the goal of optimizing recovery, minimizing complications, and reducing the risk of disease recurrence. Methods: A comprehensive literature review was conducted to identify studies on postoperative care following ESS for CRS. Findings were synthesized to develop evidence-based recommendations for optimal postoperative management. Results: Postoperative care following ESS for CRS requires a multifaceted approach. Pain management should prioritize acetaminophen and nonsteroidal anti-inflammatory drugs, with opioids reserved for severe pain. Nasal irrigation, topical corticosteroids, and debridement are recommended for all patients. Nasal packing and drug-eluting devices may offer additional benefits, but are not universally required. The use of antibiotics and oral corticosteroids should be selective and guided by individual patient factors and risk profiles. Discussion: While general recommendations are made, patient-specific factors such as comorbidities, financial constraints, and adherence to care must be considered. Further evaluation of these factors is essential to establish a more comprehensive and individualized standard of care for postoperative management. Conclusions: Effective postoperative care following ESS for CRS should be individualized, multifaceted, and focused on improving recovery, minimizing complications, and ensuring the best possible patient outcomes.
30 October 2025 in Ear, Nose & Throat Journal
Purpose of Review: The purpose of the review is to summarize current literature and evaluate the clinical implications of chronic rhinosinusitis (CRS) endotypes. Major Findings: Evolving understanding of CRS endotypes has reshaped the approach to diagnosis and treatment, from a simple phenotypic classification to a more precise molecular and immunologic framework. The differentiation between type 2 and non-type 2 inflammation has led to the development of targeted and precise therapeutic approaches, particularly with the introduction of biologic agents. Conclusions: Future advances in biomarker identification and personalized medicine will continue to further refine CRS management by supporting individualized, endotype-specific therapies that improve treatment outcomes.
19 May 2025 in Ear, Nose & Throat Journal
13 August 2025 in The Laryngoscope